Essais liés2clinical trials
VilleMarseillelocalisation
PaysFrancelocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05001737

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Emapalumab Lupus Phase 3 NCT05001737 EMERALD — Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE COMPLETED
Inebilizumab Lupus Phase 2 NCT06570798 A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases RECRUITING